» Articles » PMID: 33846434

COPD Significantly Increases Cerebral and Cardiovascular Events in Hypertensives

Overview
Journal Sci Rep
Specialty Science
Date 2021 Apr 13
PMID 33846434
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Essential hypertension and chronic obstructive pulmonary disease often coexist in the same patient. The aim of this study was to evaluate whether the addition of chronic obstructive pulmonary disease modifies the risk of cardiovascular events in hypertensives. We enrolled 1728 hypertensives. Study outcomes included fatal and non-fatal cardiovascular stroke and myocardial infarction, and cardiovascular death. During a mean follow-up of 57 months there were 205 major adverse cardiovascular events (2.47 per 100 pts/yr): cardiac (n117; 1.41 per 100 pts/yr) and cerebrovascular (n = 77; 0.93 per 100 pts/yr). In hypertensives with chronic obstructive pulmonary disease we observed a greater number of cardiovascular events than in hypertensives without respiratory disease (133 [5.55 per 100 pts/yr) vs 72 [1.22 per 100 pts/yr], respectively. The addition of chronic obstructive pulmonary disease to hypertension increased the incidence of total and non-fatal stroke of more than nine- (2.42 vs 0.32 per 100 pts/yr) and 11-fold (2.09 vs 0.22 per 100 pts/yr), respectively. The same trend was observed for total (2.88 vs 0.81 per 100 pts/yr) and non-fatal (2.67 vs 0.79 per 100 pts/y) myocardial infarction. The presence of chronic obstructive pulmonary disease in hypertensives significantly increases the risk of stroke, myocardial infarction and major adverse cardiovascular events.

Citing Articles

Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.

Yang H, Ryu M, Carey V, Kinney G, Hokanson J, Dransfield M J Am Heart Assoc. 2024; 13(11):e033882.

PMID: 38818936 PMC: 11255614. DOI: 10.1161/JAHA.123.033882.


The association between diet quality and chronic obstructive pulmonary disease: a case-control study.

Ghosn B, Onvani S, Emami Ardestani M, Feizi A, Azadbakht L, Esmaillzadeh A BMC Public Health. 2023; 23(1):2071.

PMID: 37872531 PMC: 10591368. DOI: 10.1186/s12889-023-16586-8.


Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.

Garcia A, Piccari L Curr Opin Pulm Med. 2022; 28(5):343-351.

PMID: 35838373 PMC: 9451611. DOI: 10.1097/MCP.0000000000000890.


The impact of diabetes and osteoarthritis on the occurrence of stroke, acute myocardial infarction, and heart failure among older adults with non-valvular atrial fibrillation in Hawaii: a retrospective observational cohort study.

Matsunaga M, Chen J, Jijiwa M, Lim E BMC Public Health. 2021; 21(1):1183.

PMID: 34154554 PMC: 8218453. DOI: 10.1186/s12889-021-11247-0.

References
1.
Torella D, Ellison G, Torella M, Vicinanza C, Aquila I, Iaconetti C . Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy. J Am Heart Assoc. 2014; 3(2):e000434. PMC: 4187518. DOI: 10.1161/JAHA.113.000434. View

2.
Brown J, Martinez C . Chronic obstructive pulmonary disease comorbidities. Curr Opin Pulm Med. 2016; 22(2):113-8. DOI: 10.1097/MCP.0000000000000241. View

3.
Zhang J, Rutten F, Cramer M, Lammers J, Zuithoff N, Hoes A . The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study. Fam Pract. 2011; 28(5):474-81. DOI: 10.1093/fampra/cmr024. View

4.
Perticone F, Maio R, Tripepi G, Zoccali C . Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation. 2004; 110(7):821-5. DOI: 10.1161/01.CIR.0000138745.21879.27. View

5.
Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View